In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Palantir’s current price at $158.43 substantially exceeds the PERT-weighted fair value of $75.97, indicating a potential overvaluation with a 52.1% implied downside. Despite excellent financial health scores, Monte Carlo analysis suggests significant downside risk with all scenario prices below the current market price. Diverse valuation methods yield wide ranges, reflecting high uncertainty and valuation divergence.